Timothy Melton
Optometrist · Draper, UTNPI 1669803128
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $236 of the $275 with a category attached, or 85.9%. 8 manufacturers reported payments, led by AbbVie at 49.6% of the total. Reporting peaked in 2019 at $136 and has fallen 71.8% since, to $38 in 2025. That places this record below the midpoint for optometrist clinicians in UT, where the typical reported total is $753.
Across 10 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$136
- Carl Zeiss Meditec AG$39
- Alcon$21
- Kala Pharmaceuticals, Inc.$17
- Carl Zeiss Meditec USA, Inc.$17
- Biotissue Holdings Inc.$16
- plus $29 from 2 others
What the payments were for
- Food & beverage$23686%
- Gifts$3914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 2 | $136 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Alcon | 1 | $21 |
| Kala Pharmaceuticals, Inc. | 1 | $17 |
| Carl Zeiss Meditec USA, Inc. | 1 | $17 |
| Biotissue Holdings Inc. | 1 | $16 |
| Dompe US, Inc. | 1 | $15 |
| Tarsus Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RESTASIS$125
How this compares
$275 in reported general payments places this provider in the 25th percentile of 423 optometrist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 46 | $1,452 |
| MoxifloxacinMoxifloxacin Hcl | 12 | $259 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Draper
- Jason MackayDraper$10K
- Steve LinnDraper$10K
- Stephen ReinhartHill Afb$134K
- Robert WooldridgeMurray$69K
- Ian WhippleFarr West$60K
- Rhett VeaterWest Jordan$52K
- Jonathan KingSouth Ogden$42K
- Collin GrayLehi$30K
- Sean CushmanSalt Lake City$25K
- Brian RowleyPayson$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.